[1] NIKITENKO L, BOSHOFF C. Endothelial cells and cancer [J]. Handb Exp Pharmacol, 2006, (176 Pt 2):307-334. [2] DWORACKA M, ISKAKOVA S, KRZYZAGORSKA E, et al. Alpha-lipoic acid modifies circulating angiogenic factors in patients with type 2 diabetes mellitus[J]. Diabetes Res Clin Pract, 2015, 107(2):273-279. [3] ROCHETTE L, GHIBU S, MURESAN A, et al. Alpha-lipoic acid: molecular mechanisms and therapeutic potential in diabetes[J]. Can J Physiol Pharmacol, 2015, 93(12):1021-1027. [4] NEBBIOSO M, PRANNO F, PESCOSOLIDO N.Lipoic acid in animal models and clinical use in diabetic retinopathy[J]. Expert Opin Pharmacother, 2013, 14(13):1829-1838. [5] WU J, LI X, HUANG L, et al. HSPA12B inhibits lipopolysaccharide-induced inflammatory response in human umbilical vein endothelial cells[J]. J Cell Mol Med, 2015,19(3):544-554. [6] YAO Y, LI R, MA Y, et al. Alpha-lipoic acid increases tolerance of cardiomyoblasts to glucose/glucose oxidase-induced injury via ROS-dependent ERK1/2 activation[J]. Biochim Biophys Acta, 2012,1823(4):920-929. [7] KONG Q, DAI L, WANG Y, et al. HSPA12B attenuated acute myocardial ischemia/reperfusion injury via maintaining endothelial integrity in a PI3K/Akt/mTOR-dependent mechanism[J]. Sci Rep, 2016, 6:33636. [8] MA R, WANG X, LU C, et al.Dexamethasone attenuated bupivacaine-induced neuron injury in vitro through a threonine-serine protein kinase B-dependent mechanism[J]. Neuroscience, 2010,167(2):329-342. [9] YONENAGA Y, MORI A, ONODERA H, et al. Absence of smooth muscle actin-positive pericyte coverage of tumor vessels correlates with hematogenous metastasis and prognosis of colorectal cancer patients[J]. Oncology, 2005, 69(2):159-166. [10] STEINRITZ D, BOLCK B, SCHWARZ J, et al. Effect of nacetylcysteine and alpha-linolenic acid on sulfur mustard caused impairment of in vitro endothelial tube formation[J]. Toxicol Sci, 2010, 118(2):521-529. [11] FASSINA G, VENE R, MORINI M, et al. Mechanisms of inhibition of tumor angiogenesis and vascular tumor growth by epigallocatechin-3-gallate[J]. Clin Cancer Res, 2004, 10(14):4865-4873. [12] ZIEGLER D, GRIES F A. Alpha-lipoic acid in the treatment of diabetic peripheral and cardiac autonomic neuropathy[J]. Diabetes, 1997, 46 Suppl 2: S62-S66.[13] POP-BUSUI R, STEVENS M J, RAFFEL D M, et al. Effects of triple antioxidant therapy on measures of cardiovascular autonomic neuropathy and on myocardial blood flow in type 1 diabetes: a randomised controlled trial[J]. Diabetologia, 2013, 56(8):1835-1844. [14] PARENTE E, COLANNINO G, PICCONI O, et al. Safety of oral alpha-lipoic acid treatment in pregnant women: a retrospective observational study[J]. Eur Rev Med Pharmacol Sci, 2017, 21(18):4219-4227. [15] TEKDEMIR E, TATLIPINAR A, OZBEYLI D, et al. The effects of lipoic acid and methylprednisolone on nerve healing in rats with facial paralysis[J]. Acta Otolaryngol, 2018, 138(6): 537-541. [16] LETE I, MENDOZA N, DE LA VIUDA E, et al. Effectiveness of an antioxidant preparation with N-acetyl cysteine, alpha lipoic acid and bromelain in the treatment of endometriosis-associated pelvic pain: LEAP study[J]. Eur J Obstet Gynecol Reprod Biol, 2018, 228: 221-224. [17] STEINER M K, SYRKINA O L, KOLLIPUTI N, et al. Interleukin-6 overexpression induces pulmonary hypertension[J]. Circ Res, 2009, 104(2):236-244. [18] LUO W, CHEN J, LI L, et al. C-Myc inhibits myoblast differentiation and promotes myoblast proliferation and muscle fibre hypertrophy by regulating the expression of its target genes, miRNAs and lincRNAs[J]. Cell Death Differ, 2019, 26(3):426-442. |